AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimnac-M 1 Tablet SR

Prescription Icon
Prescription Required

Marketer

Spencure Biotech Pvt. Ltd.

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimnac-M 1 Tablet SR

Dia-Comb 1 SR tablet is an antidiabetic medication combining two active agents for adult type 2 diabetes management. This formulation helps regulate blood glucose. Dia-Comb 1 SR should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to treat them. Regular meals and readily available glucose sources (e.g., sugary snacks or juice) are essential. Alcohol consumption elevates hypoglycemia risk and should be minimized. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. Dia-Comb 1 SR is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation. Regular blood glucose checks, along with blood tests to monitor blood cell counts and liver function, are recommended by your doctor.

Primary Ingredients of Glimnac-M 1 Tablet SR

No text provided. Please provide the text you wish me to rewrite.

Uses of Glimnac-M 1 Tablet SR

Managing type 2 diabetes

Major Benefits of Glimnac-M 1 Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. Glimnac-M 1 Tablet SR should be administered with a meal.

Common Side effects of Glimnac-M 1 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimnac-M 1 Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Take one Glimnac-M SR tablet with a meal.

How Glimnac-M 1 Tablet SR works:

Glimnac-M SR, a single-dose tablet, combines glimepiride and metformin to manage diabetes. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts threefold: decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimnac-M 1 Tablet SR and alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimnac-M 1 Tablet SR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against possible risks prior to prescribing. Consult your physician for guidance.

Breast feedingBreast feedingUNSAFE

Using Glimnac-M 1 Tablet SR while breastfeeding is contraindicated. Evidence indicates potential infant harm from the medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.

KidneyKidneyCAUTION

Exercise caution when administering Glimnac-M 1 Tablet SR to individuals with impaired kidney function; dosage modification may be necessary. Consult a physician for guidance. Glimnac-M 1 Tablet SR is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Exercise caution when administering Glimnac-M 1 Tablet SR to individuals with hepatic impairment; dosage modification may be necessary. Physician consultation is advised. For patients exhibiting mild to moderate liver dysfunction, initiate Glimnac-M 1 Tablet SR therapy at a reduced dosage; its use is contraindicated in those with severe liver disease.

What if you forget to take Glimnac-M 1 Tablet SR :

Should you forget to take a Glimnac-M 1 Tablet SR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication timetable. Avoid taking a double dose.

Facts to Know About Glimnac-M 1 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes medication

FAQs on Glimnac-M 1 Tablet SR

Store this medication in its original, tightly closed container as directed on the label. Dispose of any unused medication properly and keep it out of reach of children, pets, and others.
Glimnac-M 1 Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimnac-M 1 Tablet SR and seek immediate medical attention.
Glimnac-M 1 Tablet SR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. It enhances blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for type 1 DM.
Glimnac-M 1 Tablet SR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Glimnac-M 1 Tablet SR use can lead to Vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, annual supplemental Vitamin B12 intake is recommended by some researchers.
Glimnac-M 1 Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimnac-M 1 Tablet SR with alcohol is unsafe. Alcohol can worsen the drug's blood sugar-lowering effects, potentially causing hypoglycemia, and increase the risk of lactic acidosis.
Glimnac-M 1 Tablet SR
41
MRP 50
18% off